Literature DB >> 8823199

Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes.

M Dathe1, M Schümann, T Wieprecht, A Winkler, M Beyermann, E Krause, K Matsuzaki, O Murase, M Bienert.   

Abstract

An amphipathic model peptide, KLALKLALKALKAAKLA-NH2, and its complete double D-amino acid replacement set was used to analyze the process of peptide binding at lipid vesicles of different surface charge and to determine the structure of the lipid-bound peptides using CD spectroscopy. The relationship between peptide helicity, model membrane permeability, and biological activity has been studied by dye release from liposomes and investigation of antibacterial and hemolytic activity. The accumulation of cationic KLAL peptides at and the membrane-disturbing effect on bilayers of high negative surface charge were found to be dominated by charge interactions. Independent of any structural propensity, the cationic peptide side chains bind to the anionic phosphatidylglycerol moieties. The charge interactions hold the peptides at the bilayer surface, where they may disturb preferentially lipid headgroup organization by formation of peptide-lipid clusters. In contrast, KLAL peptide interaction with bilayers of low negative surface charge is highly dependent on peptide helicity. With decreasing amounts of anionic phosphatidylglycerol in the bilayer the membrane-disturbing effect of KLAL and other helical analogs substantially increases despite drastically reduced binding affinity. Less helical peptides exhibit reduced bilayer-disturbing activity, showing that the hydrophobic helix domain is decisive for binding at and inducing permeability in membranes of low negative surface charge. It is suggested that hydrophobic interactions drive the penetration of the amphipathic peptide structure into the inner membrane region, thus disturbing the arrangement of the lipid acyl chains and causing local disruption. On the basis of the proposed model for membrane disturbance, interactions modulating antibacterial and hemolytic activity are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823199     DOI: 10.1021/bi960835f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  81 in total

1.  Polar angle as a determinant of amphipathic alpha-helix-lipid interactions: a model peptide study.

Authors:  N Uematsu; K Matsuzaki
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  Characterization of the unique function of a reduced amide bond in a cytolytic peptide that acts on phospholipid membranes.

Authors:  J E Oh; K H Lee
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 3.  Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors.

Authors:  Guillaume Drin; Christophe Rousselle; Jean-Michel Scherrmann; Anthony R Rees; Jamal Temsamani
Journal:  AAPS PharmSci       Date:  2002

4.  Infrared reflection absorption spectroscopy of amphipathic model peptides at the air/water interface.

Authors:  Andreas Kerth; Andreas Erbe; Margitta Dathe; Alfred Blume
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

5.  Molecular dynamics study of substance P peptides in a biphasic membrane mimic.

Authors:  T Wymore; T C Wong
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

6.  A novel compound inhibits reconstituted high-density lipoprotein assembly and blocks nascent high-density lipoprotein biogenesis downstream of apolipoprotein AI binding to ATP-binding cassette transporter A1-expressing cells.

Authors:  Nicholas N Lyssenko; Gregory Brubaker; Bradley D Smith; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

7.  Structure-function characterization and optimization of a plant-derived antibacterial peptide.

Authors:  Mougli Suarez; Marisa Haenni; Stéphane Canarelli; Florian Fisch; Pierre Chodanowski; Catherine Servis; Olivier Michielin; Ruth Freitag; Philippe Moreillon; Nicolas Mermod
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 8.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

9.  Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.

Authors:  Christof Junkes; Richard D Harvey; Kenneth D Bruce; Rudolf Dölling; Mojtaba Bagheri; Margitta Dathe
Journal:  Eur Biophys J       Date:  2011-02-01       Impact factor: 1.733

10.  TAT peptide and its conjugates: proteolytic stability.

Authors:  Jacob Grunwald; Tomas Rejtar; Rupa Sawant; Zhouxi Wang; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2009-07-14       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.